newsfilter
← Latest News
Business Wire·

ChromaDex to Present at the Lytham Partners 2024 Investor Select Conference

ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, today announced that its Chief Executive Officer, Rob Fried, and Chief Financial Officer,